Korea United Pharm has been accelerated by the passing of the TEVA’s actual inspection inits manufacturingfacilities

The Korea United Pharm’s (executive director Duk-young Kang) completed pharmaceutical product factory has been passed for the actual inspection of TEVA.

Korea United Pharm, in the last February, has made a contract with TEVA, an Israeli multinational pharmaceutical company, to sell its first self-developed drug ‘Clanza CR Tab’ in Russia and Eastern Europe, and made an additional contract to se...